Concepedia

Craig W. Thornber

CW

Statistics

Publications

8

Citations

166

H-Index

8

Active since

1974

Affiliations

East Cheshire NHS Trust(Current)

AstraZeneca (United Kingdom)

Craig W. Thornber is an author at East Cheshire NHS Trust specializing in medicinal chemistry, pharmacology, and pharmacodynamics.

Publications per year

1974–1990

8

Publications

8

In vitro studies with ICI 169,369, a chemically novel 5-HT antagonist

Thomas P. Blackburn, Craig W. Thornber, Robert J. Pearce et al. · European Journal of Pharmacology · 1988 · 54 citations

, , +7

Synthesis and 5-hydroxytryptamine antagonist activity of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline and its analogs

Thomas P. Blackburn, Barry Cox, A. J. GUILDFORD et al. · Journal of Medicinal Chemistry · 1987 · 35 citations

, , +16

Pharmacological studies in vivo with ICI 169,369, a chemically novel 5-HT2/5-HT1C receptor antagonist

Thomas P. Blackburn, Barry Cox, Craig W. Thornber et al. · European Journal of Pharmacology · 1990 · 15 citations

, , +11

Synthetic approaches to C-18 oxygenated aspidosperma alkaloids via Organoiron Complexes

Anthony J. Pearson, David C. Rees, Craig W. Thornber · Journal of the Chemical Society Perkin Transactions 1 · 1983 · 15 citations

, , +4

The biosynthesis of hasubanonine and protostephanine

Alan R. Battersby, Raymond C. F. Jones, Rymantas Kazlauskas et al. · Journal of the Chemical Society Chemical Communications · 1974 · 14 citations

, , +9

1–5 of 8